COSCIENS Biopharma Inc 6-K, filed Feb 28, 2020
COSCIENS Biopharma Inc. (CSCIF)
About this 6-K
COSCIENS Biopharma Inc filed this 6-K on February 28, 2020.
U****NI TEDSTATES
SECURITIESAND EXCHANGECOMMISSION
Washington,D.C. 20549
F****ORM6-K
REPORTOF FOREIGNPRIVATEISSUERPURSUANT TORULE 13a-16OR 15d-16
UNDERTHE SECURITIESEXCHANGEACT OF 1934
Fo****rthe monthof February 2020
Commission File Number: 001-38064
Ae****t er n aZentarisInc.
(Translation of registrant’s name into English)
3****1 5Sigma Drive, Summerville,South Carolina,USA 29486
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [X] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1): [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (7): [ ]
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes [ ] No [X]
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-
Exhibits
| Exhibit No. | Description |
|---|---|
| 99.1 | Annual<br> Meeting Notice |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date:February 28, 2020
| AETERNA ZENTARIS INC. |
|---|
| /s/ Leslie Auld |
| Leslie Auld |
| Senior Vice President and Chief Financial Officer |
Exhibit99.1
| February<br>28, 2020 |  <br><br> <br>1500<br> Robert-Bourassa Blvd., 7th Floor<br><br> Montreal QC, H3A 3S8<br><br> www.computershare.com |
|---|
To: All Canadian Securities Regulatory Authorities
Subject:Aeterna Zentaris Inc.
Dear Sir/Madam:
We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:
| Meeting<br> Type : | Annual<br> Meeting | |
|---|---|---|
| Record<br> Date for Notice of Meeting : | April<br> 1, 2020 | |
| Record<br> Date for Voting (if applicable) : | April<br> 1, 2020 | |
| Beneficial<br> Ownership Determination Date : | April<br> 1, 2020 | |
| Meeting<br> Date : | May<br> 6, 2020 | |
| Meeting<br> Location (if available) : | Montreal, QC | |
| Issuer<br> sending proxy related materials directly to NOBO: | No | |
| Issuer<br> paying for delivery to OBO: | Yes | |
| Notice and Access (NAA) Requirements: | ||
| NAA<br> for Beneficial Holders | No | |
| NAA<br> for Registered Holders | No | |
| Voting Security Details: | ||
| Description | CUSIP Number | ISIN |
| --- | --- | --- |
| COMMON<br> SHARES | 007975402 | CA0079754028 |
Sincerely,
Computershare
Agent for Aeterna Zentaris Inc.